Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies

(2009) Wensen Chen et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma

(2009) Geir Frode Øy et al.   INTERNATIONAL JOURNAL OF CANCER

A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer

(2008) M. J. Gunter et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis

(2008) E. T. Jacobs et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study

(2008) Concetta Santonocito et al.   CLINICA CHIMICA ACTA

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients

(2008) Jessie Z Yu et al.   Journal of Translational Medicine